Metformin for Longevity: What Is and Is Not Proven
Metformin and longevity: observational survival data in diabetes, no completed trial of aging outcomes, and why it is a prescription drug for a doctor.
Researched from published studies and manufacturer specifications, checked .
We have not tested products ourselves. How we research
Quick verdict
Metformin is a prescription diabetes drug. An observational UK study found people with type 2 diabetes who started it lived at least as long as matched people without diabetes, but that cannot show metformin caused it. We found no completed randomised trial of metformin for aging outcomes in healthy people. This page gives no dosing.
Talk to your doctor first. This is general information, not medical advice. Supplements and devices can interact with medicines and health conditions. We quote study protocols for context and do not recommend doses.
The short answer: metformin is a prescription diabetes drug, and its longevity reputation rests on observational data. In UK primary-care records, people with type 2 diabetes who started metformin had survival that matched or exceeded matched people without diabetes. That cannot show metformin caused it, and it does not apply to healthy people. We found no completed randomised trial of aging outcomes. Talk to your doctor; this page gives no dosing or sourcing.
What the evidence shows
Grade: Weak for longevity in people without diabetes.
| Item | What was found | Limit |
|---|---|---|
| Bannister 2014 | 78,241 people on metformin monotherapy, 12,222 on sulphonylurea and 90,463 matched controls without diabetes; adjusted median survival in controls was 15% lower than in the metformin group (survival time ratio 0.85, CI 0.81 to 0.90) | Observational; who receives metformin is not random; people with diabetes only |
| Aging trials | We found no completed randomised trial of metformin for aging outcomes in healthy people | The TAME trial is designed to test this but had not reported in what we read |
| Versus berberine | A 36-person pilot found a similar glucose effect in new type 2 diabetes | Pilot; diabetes only |
The boundary
Metformin is prescribed and monitored, for example for kidney function. Whether it makes sense for someone without diabetes is a medical decision. See berberine vs metformin and berberine for the supplement comparison, rapamycin for the other drug in longevity discussions, and the graded supplement ladder. For tracking glucose see Stelo vs Lingo.
Method note
Read for this page: Mortality in people with type 2 diabetes on metformin or sulphonylurea vs matched controls (Diabetes Obes Metab 2014); Efficacy of berberine in type 2 diabetes, pilot with a metformin arm (Metabolism 2008). Checked 29 Sept 2026. Abstracts only. We did not test anything. General information, not medical advice.
Common questions
Does metformin extend life in healthy people?
Not shown. The best-known result is observational: in UK primary-care records, adjusted median survival in matched people without diabetes was 15% lower than in people with type 2 diabetes initiated on metformin (survival time ratio 0.85). People were not randomised, so the result cannot establish that metformin extends life, and it does not apply to people without diabetes.
Can I take metformin without diabetes?
Only a doctor can prescribe it, and using it off-label for aging is not an established indication. Ask a doctor about your own risks and monitoring. This site does not explain how to obtain or dose it.
Sources
Update log
- Sourcing pass: removed unsourced mechanism, dose and monitoring advice and 'who should consider it' lists; kept the observational survival study with its limits and the prescription boundary.
Data and comparisons
- Berberine evidence record
Often called "natural metformin"
- NMN evidence record
A direct NAD+ precursor that restores declining NAD+ levels with age
- Resveratrol evidence record
A polyphenol that activates sirtuins (SIRT1)
Related reading
Berberine vs Metformin: What Trials Compare
Berberine vs metformin: one 36-person pilot found similar glucose lowering; metformin is a prescription drug and neither is proven to extend life.
Rapamycin for Longevity: Human Evidence, Mouse Data & Risks
A source-led review of sirolimus and rapalogs: replicated mouse lifespan findings, limited human ageing studies, approved uses, safety warnings
Peptides for Longevity: What Human Evidence Exists
Peptides such as BPC-157: a 2025 review found 35 preclinical studies and one clinical study; FDA has not approved BPC-157. Information only.